Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples